Product Image

N.O.-XPLODE Grape

4.7
★ ★ ★ ★ ★
(553 ratings)
Sodium 120 mg
Potassium 200 mg
Product Image
Score51
Useful micronutrients cannot compensate for a performance blend with no assessable doses. The poor transparency makes cardiovascular suitability especially hard to judge.
How scoring works
Powder
Quantity:2 lb(s) • (60 servings)
Goals:

Score 51

Useful micronutrients cannot compensate for a performance blend with no assessable doses. The poor transparency makes cardiovascular suitability especially hard to judge.
How scoring works
$65.49($1.09 per serving)
Vitacost
$ 72.05
iHerb
$ 65.49
Report prices

Analysis

Magnesium, potassium, vitamin D, and several B vitamins are disclosed, giving the powder some basic micronutrient value. The amounts are more consistent with a pre-workout than a comprehensive heart-health formula.

The N.O.-Xplode Master Performance Blend has no meaningful amount or component breakdown in the supplied label. Buyers cannot assess its main performance ingredients or determine whether stimulants are present and at what dose.

The product is better viewed as an incompletely disclosed exercise formula than an electrolyte or cardiovascular supplement. People managing blood pressure or heart-rhythm concerns lack the information needed to judge the hidden blend.

Who is it for
  • Pre-workout users comfortable with proprietary blends
  • Adults seeking a flavored exercise powder
Best for
  • General pre-workout use rather than heart support
  • Users who do not require full active-dose disclosure

Pros

  • Lists magnesium and potassium amounts
  • Includes vitamin D and B vitamins
  • Low carbohydrate amount

Cons

  • Main performance blend is not assessable
  • Electrolyte forms are not disclosed
  • Limited value for targeted heart support

Warnings

  • The hidden performance blend prevents people with hypertension or rhythm concerns from assessing possible stimulant exposure.

Nutrient quality

56 Moderate impact

The sodium source is not identified, so its form quality cannot be assessed confidently. The 120 mg sodium amount is too low for substantial sweat replacement.

.

Ingredient transparency

42 Lower impact

A blend or combined matrix prevents full active-dose assessment. The undisclosed blend and missing excipient details materially limit transparency.

.

Customer satisfaction

62 Moderate impact

The supplied average rating is generally strong and the rating volume provides an aggregate signal. No comment-level evidence is provided to assess recurring complaints or confirm how experience matches the intended purpose.

.

Value for money

49 Lower impact

The low sodium contribution or weak disclosure limits effective value. Hidden or secondary ingredients reduce confidence in core value.

.
Report analysis

Ingredients

IngredientAmount per serving
Calories
20 Calorie(s)
Total Carbohydrates
5 Gram(s)
Vitamin D
12.5 mcg
Thiamine
2 mg
Niacin
20 mg
Vitamin B6
2 mg
Folate
330 mcg DFE
Vitamin B12
6 mcg
Pantothenic Acid
10 mg
Calcium
40 mg
Magnesium
125 mg
Sodium
120 mg
Potassium
200 mg
N.O.-Xplode Master Performance Blend
0 NP
Men 18–50 Women
Report overview
Sodium · 120 mg OverallScore58
D Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyB+ Value

The label gives a sodium amount without naming its source, limiting purity assessment. 120 mg is below the target range for intense sweat replacement; supporting electrolytes are present, but their forms do not establish high bioavailability; no trace-mineral complex or buffering compound is disclosed. The moderate carbohydrate load lowers suitability during exercise compared with a leaner formula; the serving cost is close to the market middle and offers good value.

Potassium · 200 mg OverallScore33
F Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyD- Value

The potassium amount is moderate but not high enough for focused replenishment. An unspecified form makes its absorption quality unclear, and the broader proprietary blend reduces formula transparency. Serving cost is only fair for potassium because the product is designed mainly as a pre-workout.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.
    Poorolajal J; Zeraati F; Soltanian AR; Sheikh V; Hooshmand E; Maleki A · PloS one · 2017
    Meta-analysis1,213 participants23 studies pooledHeart Health forPotassium
  2. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies.
    D'Elia L; Cappuccio FP; Masulli M; La Fata E; Rendina D; Galletti F · Nutrients · 2023
    Meta-analysis332 participants5 studies pooledHeart Health forPotassium
  3. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies.
    D'Elia L; Barba G; Cappuccio FP; Strazzullo P · Journal of the American College of Cardiology · 2011
    Meta-analysis247,510 participants11 studies pooledHeart Health forPotassium
  4. Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length.
    Behers BJ; Behers BM; Stephenson-Moe CA; Vargas IA; Meng Z; Thompson AJ; Melchor J; Wojtas CN; Rosario MA; Baker JF; Deevers AC; Mouratidis RW; Sweeney MJ · Nutrients · 2024
    Meta-analysisHeart Health forPotassium
  5. Potassium intake and risk of stroke in women with hypertension and nonhypertension in the Women's Health Initiative.
    Seth A; Mossavar-Rahmani Y; Kamensky V; Silver B; Lakshminarayan K; Prentice R; Van Horn L; Wassertheil-Smoller S · Stroke · 2015
    Cohort study90,137 participantsHeart Health forPotassium
  6. Effect of high potassium diet on endothelial function.
    Blanch N; Clifton PM; Petersen KS; Willoughby SR; Keogh JB · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2015
    Randomized trial35 participantsHeart Health forPotassium
  7. Associations between sodium, potassium, and blood pressure: results from the Hispanic Community Health Study/Study of Latinos, a prospective cohort study.
    Swift SL; Sotres-Alvarez D; Raij L; Wassertheil-Smoller S; Schneiderman N; Llabre M; Zeki Al Hazzouri A; Rundek T; Van Horn L; Daviglus M; Castaneda S; Youngblood M; Mossavar-Rahmani Y; Elfassy T · The American journal of clinical nutrition · 2024
    Cohort study11,429 participantsHeart Health forPotassium
  8. Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables.
    Toledo CC; Vellosa Schwartzmann P; Miguel Silva L; da Silva Ferreira G; Bianchini Cardoso F; Citelli Ribeiro V; Paim LR; Antunes-Correa LM; Carvalho Sposito A; Matos Souza JR; Modolo R; Nadruz W; Fernandes de Carvalho LS; Coelho-Filho OR · ESC heart failure · 2021
    Cohort study178 participantsHeart Health forPotassium
  9. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality.
    Núñez J; Bayés-Genís A; Zannad F; Rossignol P; Núñez E; Bodí V; Miñana G; Santas E; Chorro FJ; Mollar A; Carratalá A; Navarro J; Górriz JL; Lupón J; Husser O; Metra M; Sanchis J · Circulation · 2019
    Cohort study2,164 participantsHeart Health forPotassium
  10. Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
    Vardeny O; Vaduganathan M; Claggett BL; Desai AS; Jhund PS; Lam CSP; Senni M; Shah SJ; Voors AA; Zannad F; Pitt B; Matsumoto S; Merkely B; Zieroth S; Yilmaz MB; Lay-Flurrie J; Viswanathan P; Horvat-Broecker A; Scalise A; McMurray JJV; Solomon SD · JAMA cardiology · 2025
    Randomized trial6,001 participantsHeart Health forPotassium